Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo

P.S. Woll, U. Kjällquist, O. Chowdhury, H. Doolittle, D.C. Wedge, S. Thongjuea, R. Erlandsson, M. Ngara, K. Anderson, Q. Deng, A.J. Mead, L. Stenson, A. Giustacchini, S. Duarte, E. Giannoulatou, S. Taylor, M. Karimi, C. Scharenberg, T. Mortera-Blanco, I.C. MacaulayS.-A. Clark, I. Dybedal, D. Josefsen, P. Fenaux, P. Hokland, M.S. Holm, M. Cazzola, L. Malcovati, S. Tauro, D. Bowen, J. Boultwood, A. Pellagatti, J.E. Pimanda, A. Unnikrishnan, P. Vyas, G. Göhring, B. Schlegelberger, M. Tobiasson, G. Kvalheim, S.N. Constantinescu, C. Nerlov, L. Nilsson, P.J. Campbell, R. Sandberg, E. Papaemmanuil, E. Hellström-Lindberg, S. Linnarsson, S.E.W. Jacobsen

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo'. Together they form a unique fingerprint.

Immunology and Microbiology

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science